Whooping Cough: all 290 studies
Page 3 of 3. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.
- Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruSCompletedNCT02458183Phase 3
- Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After BirthCompletedNCT02428491Phase 3
- Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in ThailandCompletedNCT02408926Phase 4
- Maternal Tdap Immunization in GuatemalaCompletedNCT02301702Phase 2
- DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese InfantsCompletedNCT02274285Phase 3
- Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 WeeksStatus unknownNCT02257645
- Bordetella Pertussis Carriage in College-aged StudentsStatus unknownNCT02215564
- TDAP Safety in Pregnant WomenCompletedNCT02209623
- Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born NeonatesStatus unknownNCT02179996Phase 4
- A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their InfantsCompletedNCT02145624Phase 4
- Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in MexicoCompletedNCT02112890
- DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed InfantsCompletedNCT02094833Phase 3
- A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' AssaysCompletedNCT02072525Phase 4
- Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated PoliomyelitisCompletedNCT02040636Phase 2
- Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.CompletedNCT01993173Phase 3
- Testing the Use of Prompts to Increase Adolescent Immunization RatesCompletedNCT01984125Not applicable
- Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa VaccinationCompletedNCT01983540Phase 3
- How Does the Clinical Tool 'What's Going Around' Affect Clinical PracticeCompletedNCT01979588Not applicable
- A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and UnijectCompletedNCT01917357Phase 3
- Hepatitis B Vaccination in InfantsCompletedNCT01896596Phase 4
- Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among InfantsCompletedNCT01890850
- Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through ImmunisationCompletedNCT01890447
- Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western KenyaCompletedNCT01878435Not applicable
- Vouchers to Promote Tdap VaccinationCompletedNCT01860378Early Phase 1
- Protecting Pregnant Women From Infectious DiseasesCompletedNCT01761799Not applicable
- Vaccine Acceptance in Pregnant Minority WomenCompletedNCT01740310Not applicable
- Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare ProfessionalsCompletedNCT01706224
- Pertussis (Tdap) Vaccination in PregnancyCompletedNCT01698346Phase 4
- Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish ChildrenCompletedNCT01583049
- Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in KoreaCompletedNCT01568060
- Study of the Environmental Factors Modulating Children Immune Response in Northern SenegalCompletedNCT01545115
- Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in ChinaCompletedNCT01491087Phase 4
- Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of AgeCompletedNCT01470287Phase 3
- Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered SeparatelyCompletedNCT01457508Phase 3
- Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered ConcomitantlyCompletedNCT01457495Phase 2
- Immunogenicity and Safety of an Acellular DPT Vaccine During PregnancyCompletedNCT01445743Phase 2
- Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or OlderCompletedNCT01287949Phase 3
- Montelukast for Persistent Cough in Young People and AdultsStatus unknownNCT01279668Phase 4
- Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy AdultsCompletedNCT01267058Phase 3
- Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis VaccineCompletedNCT01262924Phase 3
- Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years OldCompletedNCT01249183Phase 3
- Tdap Vaccination for Infant CaregiversCompletedNCT01233401
- Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.CompletedNCT01214889Phase 3
- First Adult Safety Trial on Nasal Live Attenuated B. Pertussis VaccineCompletedNCT01188512Phase 1
- Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella PertussisCompletedNCT01160081
- Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis VaccinesCompletedNCT01129362
- Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control VaccineCompletedNCT01105559
- A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy InfantsCompletedNCT01062477Phase 3
- Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™CompletedNCT01061541Phase 2
- Field Trial of Maternal Influenza Immunization in AsiaCompletedNCT01034254Phase 3
- Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of AgeCompletedNCT01031303Phase 4
- A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)WithdrawnNCT01003431Phase 3
- Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable DiseaseStatus unknownNCT00932269
- Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination VaccineStatus unknownNCT00877357Phase 4
- An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine BoosterStatus unknownNCT00870350Phase 4
- Surveillance Program to Determine Product Specific Rates of Invasive Hib DiseaseCompletedNCT00855855
- Effectiveness of a Vaccination Program in the Community Ob/Gyn SettingCompletedNCT00828555
- Database Surveillance Safety Study of PENTACEL® VaccineCompletedNCT00804284
- Pertussis Vaccine in Healthy Pregnant WomenCompletedNCT00707148Phase 1
- Phase IV Interchangeability Study of a Liquid Pentavalent Combination VaccineCompletedNCT00674908Phase 4
- Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended VaccineCompletedNCT00662870Phase 3
- Safety and Immunogenicity Study of a Liquid Pentavalent Combination VaccineCompletedNCT00617812Phase 4
- Pertussis Maternal Immunization StudyCompletedNCT00553228Phase 2/3
- Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of AgeCompletedNCT00524732
- Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio VaccineCompletedNCT00514059Phase 4
- Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 MonthsCompletedNCT00453570Phase 3
- Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®CompletedNCT00362427Phase 2
- Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar®CompletedNCT00355654Phase 3
- Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and ToddlersCompletedNCT00343421Phase 3
- The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant RecipientsStatus unknownNCT00336115Phase 4
- Immunogenicity and Safety of Tetraxim Versus Local DTP + IPVCompletedNCT00319852Phase 3
- Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination SchedulesCompletedNCT00316147Phase 3
- Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to InfantsCompletedNCT00291967Phase 2
- Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in InfantsCompletedNCT00287092Phase 3
- Immunogenicity and Safety of Pentaxim™ in an Indian PopulationCompletedNCT00259337Phase 3
- Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in ThailandCompletedNCT00255021Phase 4
- Immunogenicity and Safety of Pentaxim in South African InfantsCompletedNCT00254969Phase 3
- Assessment of the Immunogenicity and Safety of PENTAXIM™ in PhilippinesCompletedNCT00254917Phase 4
- Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in InfantsCompletedNCT00197275Phase 3
- Vaccination of Children Following Allogeneic Stem Cell TransplantationCompletedNCT00169728Phase 3
- Immunology of Non-specific Effects of VaccineCompletedNCT00168545Phase 4
- Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 MthsCompletedNCT00158808Phase 2
- Pilot Study Freeze and Transport Immune CellsCompletedNCT00138268
- Pentavalent DTaP-Hep B-IPVCompletedNCT00133445Phase 2
- A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td VaccineCompletedNCT00109330Phase 3
- Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)CompletedNCT00092469Phase 3
- Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV DrugsCompletedNCT00013871Not applicable
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis VaccinesCompletedNCT00004800Phase 3
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis VaccinesCompletedNCT00004799Phase 3
- Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis InfectionCompletedNCT00004422Phase 3